HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human Milk Oligosaccharides Activate Epidermal Growth Factor Receptor and Protect Against Hypoxia-Induced Injuries in the Mouse Intestinal Epithelium and Caco2 Cells.

AbstractBACKGROUND:
Hypoxia-induced intestinal barrier injuries lead to necrotizing enterocolitis (NEC). Although NEC in preterm neonates is preventable by human milk oligosaccharides (HMOs), the underlying mechanism remains unknown.
OBJECTIVE:
To reveal the role and mechanism of HMOs in protecting against hypoxia-induced injuries in intestinal epithelium of neonatal mice and cultured Caco2 cells.
METHODS:
NEC was induced by hypoxia and cold stress. Seventy C57BL/C pups (7-d-old) were divided into 5 groups and fed maternal breast milk (BM), formula alone (FF), or the formula added with HMOs at 5 (LHMO), 10 (MHMO), or 20 mg/mL (HHMO) for 3 d. Ileal hypoxia inducible factor 1α (HIF1α) and cleaved Caspase 3 were determined, along with staining for Ki-67 protein to labeled proliferative cells. In vitro, adherent Caco2 cells (undifferentiated, passage 14) were treated with HMOs, galacto-oligosaccharides, fructo-oligosaccharides, or mixed oligosaccharides at 10 mg/mL for 1 d exposed to 1% O2. Cell proliferation and apoptosis, along with phosphorylated epidermal growth factor receptor (P-EGFR) and 38KD MAPK (P-P38), were assayed in differentiated or undifferentiated Caco2 cells.
RESULTS:
Compared with the FF-fed mice, those fed MHMO and HHMO had 52% lower (P < 0.05) NEC scores, 60-80% greater (P < 0.05) KI67-positive cell numbers, and 56-71% decreases (P < 0.05) in ileal HIF1α and cleaved Caspase 3 (56-71%). Compared with those untreated, the HMO-treated Caco2 cells displayed 60% greater (P < 0.05) proliferative activity and 19% lower (P < 0.05) apoptotic cells after the hypoxia exposure. The HMO treatment led to 58% or 10-fold increases (P < 0.05) of P-EGFR and 48-89% decreases (P < 0.05) of P-P38 in either differentiated or undifferentiated Caco2 cells compared with the controls.
CONCLUSION:
Supplementing HMOs at 10-20 mg/mL into the formula for neonatal mice or media for Caco2 cells conferred protection against the hypoxia-induced injuries. The protection in the Caco2 cells was associated with an activation of EGFR.
AuthorsChenyuan Wang, Ming Zhang, Huiyuan Guo, Jingyu Yan, Lingli Chen, Wendi Teng, Fazheng Ren, Yiran Li, Xifan Wang, Jie Luo, Yixuan Li
JournalThe Journal of nutrition (J Nutr) Vol. 150 Issue 4 Pg. 756-762 (04 01 2020) ISSN: 1541-6100 [Electronic] United States
PMID31915826 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © The Author(s) 2020.
Chemical References
  • Oligosaccharides
  • ErbB Receptors
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Animals, Newborn
  • Apoptosis (drug effects)
  • Caco-2 Cells
  • Cell Proliferation (drug effects)
  • Enterocolitis, Necrotizing (etiology, pathology, prevention & control)
  • ErbB Receptors (drug effects, metabolism)
  • Female
  • Humans
  • Hypoxia (complications, pathology)
  • Intestinal Mucosa (drug effects, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Milk, Human (chemistry)
  • Oligosaccharides (administration & dosage)
  • Phosphorylation (drug effects)
  • p38 Mitogen-Activated Protein Kinases (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: